← Leaderboards

Karen Sue Anderson

Dana-Farber Cancer Institute

Google Scholar ↗PubMed ↗ORCID ↗

$9,175,456

Attributed

$17,029,034

Total exposure

11

Grants

7

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY2005–25

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$20,527,749 · 12

By mechanism

U01$9,284,860 · 3

U2C$4,822,849 · 3

UH3$2,424,222 · 1

R01$1,584,854 · 1

R21$1,062,588 · 2

UG3$714,821 · 1

Top collaborators

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Fabio C Re$7,327,370

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsAntibodiesBiological MarkersValidationEnzyme-Linked Immunosorbent AssayDetectionSerumScreening For CancerTechnologyLaboratoriesPredictive ValueScreeningHuman PapillomavirusPerformanceAutoantibodiesBlindedDesignEarly Detection Research NetworkValidation StudiesCancer PatientMorbidity - Disease RateProtein MicrochipsAntigensBreast

Grant awards (47)

Southwest EDRN Clinical Validation Center for Head and Neck Cancer$1,008,620

U01 · FY2025 · CA · contact PI

High-throughput immunoproteomics for cancer biomarker discovery$967,342

U2C · FY2025 · CA

Biomarker Developmental Laboratory$263,057

U2C · FY2025 · CA · contact PI

Southwest EDRN Clinical Validation Center for Head and Neck Cancer$963,127

U01 · FY2024 · CA · contact PI

High-throughput immunoproteomics for cancer biomarker discovery$858,891

U2C · FY2024 · CA

Biomarker Developmental Laboratory$235,832

U2C · FY2024 · CA · contact PI

High-throughput immunoproteomics for cancer biomarker discovery$962,182

U2C · FY2023 · CA

Southwest EDRN Clinical Validation Center for Head and Neck Cancer$747,673

U01 · FY2023 · CA · contact PI

Biomarker Developmental Laboratory$367,883

U2C · FY2023 · CA · contact PI

Rapid Point of Care Detection of HPV-Associated Malignancies$821,873

UH3 · FY2022 · CA · contact PI

High-throughput immunoproteomics for cancer biomarker discovery$710,300

U2C · FY2022 · CA

Biomarker Developmental Laboratory$457,362

U2C · FY2022 · CA · contact PI

Rapid Point of Care Detection of HPV-Associated Malignancies$823,353

UH3 · FY2021 · CA · contact PI

Novel approaches to study immune responses to post translational modifications for cancer detection$183,239

U01 · FY2021 · CA

Novel approaches to study immune responses to post translational modifications for cancer detection$448,752

U01 · FY2020 · CA

Rapid Point of Care Detection of HPV-Associated Malignancies$1

UH3 · FY2020 · CA · contact PI

Rapid Point of Care Detection of HPV-Associated Malignancies$778,995

UH3 · FY2019 · CA · contact PI

Novel approaches to study immune responses to post translational modifications for cancer detection$439,654

U01 · FY2019 · CA

Novel approaches to study immune responses to post translational modifications for cancer detection$607,578

U01 · FY2018 · CA

Rapid Point of Care Detection of HPV-Associated Malignancies$338,933

UG3 · FY2018 · CA · contact PI

Novel approaches to study immune responses to post translational modifications for cancer detection$462,286

U01 · FY2017 · CA

Rapid Point of Care Detection of HPV-Associated Malignancies$375,888

UG3 · FY2017 · CA · contact PI

Rapid Disease Diagnostics using Photonic Crystal Enhanced Antigen Biomarker$373,052

R01 · FY2017 · GM

Single Cell Technologies for Rapid Detection of Tumor Heterogeneity$204,524

R21 · FY2017 · CA · contact PI

Novel approaches to study immune responses to post translational modifications for cancer detection$480,733

U01 · FY2016 · CA

Rapid Disease Diagnostics using Photonic Crystal Enhanced Antigen Biomarker$374,785

R01 · FY2016 · GM

Single Cell Technologies for Rapid Detection of Tumor Heterogeneity$238,128

R21 · FY2016 · CA · contact PI

Rapid Disease Diagnostics using Photonic Crystal Enhanced Antigen Biomarker$388,913

R01 · FY2015 · GM

Single Cell Technologies for Rapid Detection of Tumor Heterogeneity$251,753

R21 · FY2015 · CA · contact PI

Biomarker Detection Using NAPPA Tumor Antigen Arrays$226,286

U01 · FY2015 · CA

Biomarker Detection Using NAPPA Tumor Antigen Arrays$710,359

U01 · FY2014 · CA

Rapid Disease Diagnostics using Photonic Crystal Enhanced Antigen Biomarker$448,104

R01 · FY2014 · GM

Biomarker Detection Using NAPPA Tumor Antigen Arrays$192,353

U01 · FY2014 · CA

Biomarker Detection Using NAPPA Tumor Antigen Arrays$689,664

U01 · FY2013 · CA

Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer$155,627

R21 · FY2013 · CA · contact PI

Biomarker Detection Using NAPPA Tumor Antigen Arrays$55,024

U01 · FY2013 · CA

Biomarker Detection Using NAPPA Tumor Antigen Arrays$730,476

U01 · FY2012 · CA

Mutation-Specific p53 Antibodies as Biomarkers of Pancreatic Cancer$212,556

R21 · FY2012 · CA · contact PI

Biomarker Detection Using NAPPA Tumor Antigen Arrays$58,809

U01 · FY2012 · CA

Biomarker Detection Using NAPPA Tumor Antigen Arrays$639,172

U01 · FY2011 · CA

Biomarker Detection Using NAPPA Tumor Antigen Arrays$641,055

U01 · FY2010 · CA

MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS$63,355

K08 · FY2005 · CA

MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS$126,711

K08 · FY2004 · CA

MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS$126,711

K08 · FY2003 · CA

MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS$63,356

K08 · FY2002 · CA

MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS$126,711

K08 · FY2001 · CA

MEASUREMENT OF CTL RESPONSES TO HUMAN PAPILLOMA VIRUS$126,711

K08 · FY2000 · CA